Page 3 - Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 27, 2024

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

127 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6586

CHO Pharma
NT$50.90-1.0%-27.7%NT$10.9bn/aPS10067.6xn/an/a

6926

Shine-On BioMedicalLtd
NT$67.001.8%5.5%NT$3.3bn/aPS350.3xn/an/a

4108

PhytoHealth
NT$16.502.5%-28.9%NT$3.3bn/aPS20.1xn/an/a

6986

HeXun Biosciences
NT$70.10-4.5%1.0%NT$3.2bn/aPE26xn/an/a

6617

Gongwin Biopharm Holdings
NT$118.5010.7%-31.1%NT$15.1bn/aPS475.7xn/an/a

6709

Advagene Biopharma
NT$19.40-3.2%-25.2%NT$1.2bn/aPB10.6xn/an/a

6876

LAUNXP Biomedical
NT$18.7010.0%n/aNT$601.9mn/an/an/an/a

4114

Synmosa Biopharma
NT$34.40-0.9%-7.9%NT$14.5bNT$36.00PE20.1xS12.7%1.6%

4747

Johnson Chemical Pharmaceutical Works
NT$69.10-1.3%-21.5%NT$3.1bn/aPE37.9xn/a2.2%

7773

FullHope BiomedicalLtd
NT$40.55-3.7%n/aNT$1.6bn/an/an/an/a

4123

Center Laboratories
NT$50.10-0.2%9.2%NT$36.1bn/aPS22.9xn/a3.0%

6838

Formosa Pharmaceuticals
NT$38.70-1.4%-23.1%NT$5.8bn/aPS42.5xn/an/a

6955

Bonraybio
NT$142.503.6%96.5%NT$2.8bn/an/an/a0.1%

6652

Eusol BiotechLtd
NT$7.500.7%-23.5%NT$1.0bn/aPB2.7xn/an/a

1783

Maxigen Biotech
NT$43.703.1%-10.3%NT$3.9bn/aPE25.1xn/a2.3%

4194

Holy Stone Healthcare
NT$14.00-6.0%-34.3%NT$2.0bn/aPS9.2xn/an/a

7776

Anya Biopharm
NT$47.70-2.9%n/aNT$2.3bn/an/an/an/a

4167

Savior Lifetec
NT$20.45-0.2%-2.6%NT$6.5bn/aPE36.1xn/a0.4%

6562

UBI Pharma
NT$14.251.8%-62.3%NT$1.7bn/aPE2097.4xn/a0%

6657

Energenesis BiomedicalLTD
NT$56.4010.8%-15.1%NT$4.3bn/aPS581.9xn/an/a

7729

Steminent Biotherapeutics
NT$22.801.1%n/aNT$1.3bn/an/an/an/a

1777

SYN-TECH Chem. & Pharm
NT$99.603.0%14.9%NT$4.4bn/aPE13.6xn/a3.5%

4157

TaiGen Biopharmaceuticals Holdings
NT$12.10-2.8%-23.9%NT$8.7bn/aPE50.6xn/an/a

3176

Medigen Biotechnology
NT$34.901.9%-33.9%NT$4.9bn/aPS3.4xn/an/a
Page 3 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.